Pharmacologic Vitreolysis
The vitreoretinal interface is involved in a wide range of vitreoretinal disorders and separation of the posterior vitreous face from the retinal surface is an essential part of vitrectomy surgeries. A diverse range of enzymatic and non-enzymatic agents are being studied as an adjunct before or duri...
Main Authors: | Hossein Nazari, Mehdi Modarres-Zadeh, Arash Maleki |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2010-01-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2010;volume=5;issue=1;spage=44;epage=52;aulast=Nazari;type=0 |
Similar Items
-
Clinical observation of Ultra Q-YAG vitreolysis for vitreous floaters
by: Jing Li, et al.
Published: (2016-07-01) -
A New Pharmacological Vitreolysis through the Supplement of Mixed Fruit Enzymes for Patients with Ocular Floaters or Vitreous Hemorrhage-Induced Floaters
by: Jui-Wen Ma, et al.
Published: (2022-11-01) -
Rapid Cataract Progression after Nd:YAG Vitreolysis for Vitreous Floaters: A Case Report and Literature Review
by: I-Ting Sun, et al.
Published: (2017-05-01) -
Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial
by: Zhou Hangshuai, et al.
Published: (2024-01-01) -
Pneumatic vitreolysis for management of symptomatic focal vitreomacular traction
by: Clement K Chan, et al.
Published: (2017-01-01)